The veterinary CBD market size is valued at USD million in 2021 and is poised to grow at a significant CAGR over 2022–2028. The potential therapeutic applications of CBD in the context of evidence-based medicine, especially in dogs and horses in relation to the treatment of pain, epilepsy, and anxiety in order to give veterinarians a succinct summary of scientific results in this area. Increasing interest in the therapeutic approach in veterinary medicine is logically connected to expanding the use of cannabinoids or medical cannabis in human. Due to legal restrictions, the use of medical cannabis for veterinary purposes is not permitted in many nations; however, the use of CBD alone is generally possible. However, the number of trustworthy sources for the clinical use of cannabis in veterinary medicine is substantially smaller. Cannabidiol (CBD) products have become very popular recently, both among pet owners and in the veterinary field. Over-the-counter hemp-based CBD is extremely well-liked due to its widespread accessibility and Internet “buzz,” and cannabis, in general, has turned into one of the most influential natural medications to be brought into contemporary veterinary practice.
In Feb 2019, Canopy Growth and Martha Stewart worked together to introduce a line of CBD-infused animal health products.